(Q33719938)

28 July 2017

1 reference

title

Superior vena cava syndrome (English)

1 reference

28 July 2017

Haapoja IS

1

1 reference

28 July 2017

Blendowski C

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Seminars in Oncology Nursing

28 July 2017

published in

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

183-189

1 reference

Small cell lung cancer with and without superior vena cava syndrome: A multivariate analysis of prognostic factors in 408 cases

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Superior vena cava syndrome in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

A contemporary perspective on superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Diagnosis and management of superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

The use of the Wallstent endovascular prosthesis in the treatment of malignant obstruction of the superior vena cava

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Superior vena cava obstruction in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Approach to the patient who presents with superior vena cava obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Hypofractionated radiation therapy in the treatment of superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Safety and efficacy of thrombolytic therapy for superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

Superior vena cava syndrome: an oncologic complication

1 reference

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-2081%2899%2980006-0

1 reference

7 January 2021

10.1016/S0749-2081(99)80006-0

Identifiers

DOI

1 reference

28 July 2017

1 reference